63 related articles for article (PubMed ID: 9757278)
21. Adverse drug reactions and reporting.
Witte R
Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
[No Abstract] [Full Text] [Related]
22. Vaccine adverse event reporting: the importance of follow-up.
Varricchio F
Expert Rev Vaccines; 2005 Aug; 4(4):445-8. PubMed ID: 16117700
[No Abstract] [Full Text] [Related]
23. Adverse drug reactions, MedWatch reporting and medical student education.
Lewis LD; Nierenberg DW
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):93-5. PubMed ID: 12642972
[No Abstract] [Full Text] [Related]
24. Similarity and difference in the acute lung injury induced by a radiographic contrast medium and an anticancer agent paclitaxel in rats.
Itoh Y; Sendo T; Hirakawa T; Goromaru T; Sakai N; Nakano H; Oishi R
Toxicol Lett; 2004 Aug; 152(1):27-34. PubMed ID: 15294344
[TBL] [Abstract][Full Text] [Related]
25. Reporting adverse vaccine events.
O'Rourke K
J Am Vet Med Assoc; 2003 Sep; 223(6):753-4. PubMed ID: 14507079
[No Abstract] [Full Text] [Related]
26. Bubble trouble?
ter Haar G
Ultraschall Med; 2008 Oct; 29(5):550-1. PubMed ID: 18937172
[No Abstract] [Full Text] [Related]
27. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
[TBL] [Abstract][Full Text] [Related]
28. MedWatch targets reporting of serious adverse events.
VanAmringe M
Jt Comm Perspect; 1993; 13(4):15. PubMed ID: 10129237
[No Abstract] [Full Text] [Related]
29. Thrombogenic potential of non-ionic contrast media--fact or fiction? By Rainer Schrader.
Chronos N; Blanco J
Eur J Radiol; 1998 Aug; 28(1):106-7. PubMed ID: 9717632
[No Abstract] [Full Text] [Related]
30. Improving adverse drug reaction reporting in the community setting.
McCloskey BA
Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
[TBL] [Abstract][Full Text] [Related]
31. Improving the quality of adverse drug reaction reporting by 4th-year medical students.
Rosebraugh CJ; Tsong Y; Zhou F; Chen M; Mackey AC; Flowers C; Toyer D; Flockhart DA; Honig PK
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):97-101. PubMed ID: 12642973
[TBL] [Abstract][Full Text] [Related]
32. Recognizing, reporting, and reducing adverse drug reactions.
Brown SD; Landry FJ
South Med J; 2001 Apr; 94(4):370-3. PubMed ID: 11332899
[TBL] [Abstract][Full Text] [Related]
33. Impact of new regulations for pediatric labeling by the Food and Drug Administration.
Buck ML
Pediatr Nurs; 2000; 26(1):95-6. PubMed ID: 12026326
[No Abstract] [Full Text] [Related]
34. E-mail, snail mail, phone, or fax. Reporting adverse reactions and other product problems.
Henkel J
FDA Consum; 1998; 32(6):7-9. PubMed ID: 9854444
[No Abstract] [Full Text] [Related]
35. Strategy for surveillance of adverse drug events.
Bright RA
Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
[No Abstract] [Full Text] [Related]
36. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
37. Adverse drug reporting issues for managers.
Sperling RL
Home Healthc Nurse Manag; 1999; 3(6):26-9. PubMed ID: 10876507
[No Abstract] [Full Text] [Related]
38. Adverse event reporting: essential for science and public trust.
Verma IM
Mol Ther; 2001 Aug; 4(2):83. PubMed ID: 11482977
[No Abstract] [Full Text] [Related]
39. [Adverse effects of contrast media: results of a 6 months study].
Pelagatti V; Bagheri H; Fernandez P; Railhac N; Bregeon C; Railhac JJ; Montastruc JL
Therapie; 2000; 55(3):391-4. PubMed ID: 10967718
[TBL] [Abstract][Full Text] [Related]
40. Effects of ioxaglate on cultured microvascular endothelial cells: do all in vitro studies actually reflect clinical situations?
Idée JM; Prigent P; Corot C
Acad Radiol; 2002 Jan; 9(1):98-100. PubMed ID: 11918364
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
